As serum AFP has proven to be a dependable biomarker for the diagnosis of HCC, pre-diagnostic screening programs, and the assessment of survival, we assessed AFP using other inflammation-based and immunonutritional scoring systems. Here, AFP is linked to hepatocellular carcinoma.